popup

TOCIVID (sarilumab), 0 NCT04322773

sarilumab vs. standard of care

COVID 19 all comers

sarilumab phase 2 high dose, 0 NCT04315298

sarilumab high dose (400mg) vs. placebo

COVID 19 all comers

sarimulab phase 2 low dose, 0 NCT04315298

sarilumab low dose (200mg) vs. placebo

COVID 19 all comers

CORIMUNO-SARI-1 (non ICU), 2021 NCT04324073

sarilumab vs. standard of care

COVID 19 hospitalized

SARICOR, 0 NCT04357860

sarilumab vs. standard of care

COVID 19 hospitalized

SARCOVID, 0 NCT04357808

sarilumab vs. standard of care

COVID 19 hospitalized

sarilumab Sanofi phase 3 US, 0 NCT04315298

sarilumab vs. control

COVID-19 severe or critically

ARI-RAF (Della-Torre), 2020

sarilumab vs. control

COVID-19 severe or critically

sarilumab Sanofi phase 3 outside US, 0

sarilumab vs. placebo

COVID-19 severe or critically

REMAP-CAP sarilumab, 2021 NCT02735707

sarilumab vs. standard of care

COVID-19 severe or critically

CORIMUNO-VIRO, 0 NCT04341870

sarilumab azithromycin hydroxychloroquine vs. sarilumab

COVID-19 severe or critically

Lescure (Sarilumab 400mg), 2021 NCT04327388

sarilumab high dose (400mg) vs. placebo

COVID-19 severe or critically

Lescure (Sarilumab 200mg), 2021 NCT04327388

sarilumab low dose (200mg) vs. placebo

COVID-19 severe or critically